Insights

Innovative Platform Laronde's proprietary Endless RNA technology offers a versatile platform for developing novel therapeutic solutions across multiple disease areas, providing opportunities to partner or supply unique RNA-based products.

Strong Financial Backing With recent Series B funding of $440 million, Laronde has substantial capital to expand production capacity, invest in R&D, and accelerate clinical development, making it an attractive partner for biotech service providers and suppliers.

Strategic Collaborations Laronde's partnership with Senda Biosciences highlights its openness to collaboration with innovative companies leveraging AI and microbiome data, presenting avenues for joint ventures and integrated solutions in biotech and pharma.

Rapid Growth Trajectory Founded in 2017 with ambitious goals to develop 100 eRNA medicines within 10 years, Laronde's aggressive development plans suggest high demand for CROs, manufacturing partners, and regulatory consultants to support scalability.

Market Expansion Operating in the biotech research sector with a focus on personalized medicine, Laronde offers opportunities to supply research tools, biotech equipment, and tech services tailored to innovative, biological therapies in development.

Laronde Tech Stack

Laronde uses 8 technology products and services including CIM Technologies, GitHub, NoSQL, and more. Explore Laronde's tech stack below.

CIM Technologies

Cad & Graphics

GitHub

Communication And Collaboration

NoSQL

Database

PostgreSQL

Database

ADP

Human Resource Management System

AngularJS

Javascript Frameworks

Python

Programming Languages

Django

Web Frameworks

Laronde Email Formats	Example	Percentage
FLast@laronde.bio	JDoe@laronde.bio	97%
First_Last@laronde.bio	John_Doe@laronde.bio	3%

Laronde Email Formats

Example

Percentage

FLast@laronde.bio

JDoe@laronde.bio

97%

First_Last@laronde.bio

John_Doe@laronde.bio

Frequently Asked Questions

Where is Laronde's headquarters located?

Laronde's main headquarters is located at 55 Cambridge Parkway Suite 800e Cambridge, Massachusetts United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Laronde's official website and social media links?

Laronde's official website is laronde.bio and has social profiles on LinkedIn Crunchbase.

What is Laronde's SIC code NAICS code?

Laronde's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Laronde have currently?

As of April 2026, Laronde has approximately 44 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Lab Manager: L. K.Senior Accounts Payable Specialist: S. D.Senior Research Associate: P. Q.. Explore Laronde's employee directory with LeadIQ.

What industry does Laronde belong to?

Laronde operates in the Biotechnology Research industry.

What technology does Laronde use?

Laronde's tech stack includes CIM TechnologiesGitHubNoSQLPostgreSQLADPAngularJSPythonDjango.

What is Laronde's email format?

Laronde's email format typically follows the pattern of FLast@laronde.bio. Find more Laronde email formats with LeadIQ.

How much funding has Laronde raised to date?

As of April 2026, Laronde has raised $440M in funding. The last funding round occurred on Aug 30, 2021 for $440M.

When was Laronde founded?

Laronde was founded in 2017.

Laronde

Q: What is Laronde's official website and social media links?

Laronde's official website is laronde.bio. Laronde has social profiles on LinkedIn.

Q: How many employees does Laronde have currently?

Laronde has approximately 44 employees.

Q: What technology does Laronde use?

Laronde's tech stack includes Okta, MySQL, NoSQL, PostgreSQL, ADP.

Q: What is Laronde's NAICS code?

Laronde's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchMassachusetts, United States11-50 Employees

Laronde is pioneering a platform that offers a completely novel way of modulating human biology. Endless RNA™ (eRNA), is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.

Insights

Similar companies to Laronde

Kings Dominion

Six Flags Magic Mountain

Carowinds

Canada's Wonderland

Worlds of Fun

Knott's Berry Farm

California's Great America

Kings Island

Laronde Tech Stack

Media & News

Laronde receives financing of $440M in Series B.

Laronde partners with Senda Biosciences, Inc..

Laronde is developing eRNA based therapies on Jan 1st '22.

Flagship Pioneering Company invested into Laronde $50M in financing on Jan 5th '22.

Laronde's Email Address Formats